In this video, Pinkal Desai, MD, MPH, Weill Cornell Medical College, New York, NY, shares her insights on a discussion held at ASH 2021, which focused on the development of guidelines for older patients with acute myeloid leukemia (AML). First, Dr Desai gives a detailed description of the process behind developing these guidelines, which were formed using a rigorous meta-analysis, and involved answering a variety of specific questions. Following this, Dr Desai goes on to explain what was presented at ASH, and briefly mentions the need to regularly update the guidelines based on novel data, such as FLT3 inhibitors and oral azacitidine. This interview took place at the 63rd ASH Annual Meeting and Exposition Congress, Atlanta, GA, 2021.
